Investors

Since its founding in 2016, Ikena has raised over $160 million from leading life sciences investors and companies that include Atlas Venture, OrbiMed, BMS, Omega Funds, Fidelity Management and Research Company, Surveyor Capital (a Citadel company), Invus, Farallon Capital Management, BVF Partners, L.P., Cowen Healthcare Investments, Logos Capital, and HealthCor Management.

Merck
Merck
Merck
Merck
Merck
Merck
Merck
Merck
Celgene Corporation
Celgene Corporation
Celgene Corporation
Celgene Corporation

Reach out to find out more about how we are discovering and developing cancer therapies.